DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Millot F, Guilhot J, Nelken B. et al.
Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation.

Leukemia 2006;
20 (02) 187-192

Download Bibliographical Data

Access:
Access: